Spots Global Cancer Trial Database for unrelated donor
Every month we try and update this database with for unrelated donor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY | NCT00809276 | Lymphoma Multiple Myelom... Leukemia Myelodysplastic... | Busulfan, Fluda... | - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells | NCT01624701 | Acute Leukemia Chronic Leukemi... Myelodysplastic... Lymphoma Myeloma | Ex vivo expande... | 12 Years - 60 Years | Singapore General Hospital | |
| Selecting a Favorable KIR Donor in Unrelated HCT for AML | NCT01288222 | Acute Myelogeno... | KIR genotype | - | Masonic Cancer Center, University of Minnesota | |
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells | NCT01624701 | Acute Leukemia Chronic Leukemi... Myelodysplastic... Lymphoma Myeloma | Ex vivo expande... | 12 Years - 60 Years | Singapore General Hospital | |
| Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) | NCT01295710 | GVHD Adult Acute Mye... Adult Acute Lym... Myelodysplastic... | US-ATG-F Placebo | 18 Years - 65 Years | Neovii Biotech | |
| PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT | NCT04669210 | Graft-versus-ho... Stem Cell Trans... Acute Myeloid L... Acute Lymphoid ... | Ruxolitinib Tacrolimus Mycophenolate M... | 18 Years - 70 Years | St. Petersburg State Pavlov Medical University | |
| Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation | NCT02188290 | Acute Myeloid L... Acute Lymphobla... Myelodysplastic... | 18 Years - 65 Years | Kiadis Pharma | ||
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells | NCT01624701 | Acute Leukemia Chronic Leukemi... Myelodysplastic... Lymphoma Myeloma | Ex vivo expande... | 12 Years - 60 Years | Singapore General Hospital | |
| Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) | NCT04965597 | Bone Marrow Fai... Congenital Ameg... Congenital Pure... Hereditary Side... Paroxysmal Noct... Shwachman-Diamo... Hematologic Neo... Hematologic Neo... Hematologic Neo... | Treosulfan Fludarabine Pho... Tacrolimus Methotrexate Lapine T-Lympho... Peripheral Bloo... Allogeneic Bone... Quality-of-Life... Echocardiograph... Multigated Acqu... Bone Marrow Bio... Bone Marrow Asp... Biospecimen Col... | 1 Year - 49 Years | Fred Hutchinson Cancer Center | |
| Selecting a Favorable KIR Donor in Unrelated HCT for AML | NCT01288222 | Acute Myelogeno... | KIR genotype | - | Masonic Cancer Center, University of Minnesota | |
| Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation | NCT02188290 | Acute Myeloid L... Acute Lymphobla... Myelodysplastic... | 18 Years - 65 Years | Kiadis Pharma | ||
| Reduced Intensity AlloSCT in(CML) With Persistent Disease | NCT00531310 | Chronic Myeloid... | Reduced Intensi... | - 30 Years | Columbia University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
